Due to fraudulence and misconduct in research, advances in Alzheimer’s Disease treatments have been hindered. Read More.
Other Posts
AI Governance: Representation or Real Influence?
The UN has released the Co-Chairs' Summary from its first Global Dialogue on AI Governance, held in Geneva in July 2026. The Dialogue brought governments and other stakeholders together to address issues including AI safety, [...]
Whose Malaria Becomes an Emergency?
Six Frankfurt Airport workers contracted malaria this summer after mosquitoes were likely carried into Germany on a flight, and two died. The outbreak prompted a rapid investigation, mosquito trapping, and efforts to determine where the [...]
Hear From Our Interns and Join the 2026 BEI Winter School
Applications are now open for the 2026 Bioethics Education International Online Winter School, taking place December 14-18, 2026. This year’s theme, Bioethics in a New World Order, will bring together students and professionals from around [...]
Who Protects Patients at Psychedelic Clinics Abroad?
As interest in psychedelic therapy grows, more Americans are traveling abroad for treatments that remain restricted in the United States. Reports of inadequate medical screening, serious complications, and sexual abuse have raised concerns about patient [...]
New Study Finds CTE in at Least One in Four Former NFL Players
A new study found that at least one in four former NFL players who died between 2016 and 2021 had chronic traumatic encephalopathy, or CTE, a degenerative brain disease associated with repeated head impacts. Researchers [...]
Harvard Turns Professors Into AI Clones
Harvard Business School has launched a $699 AI powered entrepreneurship bootcamp, H.B.S. Foundry, featuring interactive video avatars of its faculty for practicing pitches, sales calls, and board meetings. The AI clones are trained on specific [...]
